Global DNA Forensics Market Size, Share, Trends & Growth Analysis Report 2026-2034

The global DNA forensics market size is expected to reach USD 7.28 Billion in 2034 from USD 3.81 Billion in 2025, growing at a CAGR of 7.44 during 2026-2034.This market is expanding rapidly due to increasing demand for accurate identification and investigation tools in criminal justice and legal systems. DNA forensics technology is widely used for crime scene analysis, paternity testing, and disaster victim identification. The growing need for reliable and rapid forensic solutions is significantly driving market growth across the globe.

Key drivers include advancements in DNA sequencing technologies and increasing adoption of forensic databases. Governments and law enforcement agencies are investing in modern forensic laboratories to improve investigation efficiency. The rising number of criminal cases and growing awareness about forensic science are also contributing to market expansion. Additionally, technological innovations are enabling faster and more precise analysis.

The future outlook for the DNA forensics market remains strong, with continuous developments in genomic technologies and data analysis tools. The integration of automation and artificial intelligence will enhance processing speed and accuracy. Emerging markets are expected to provide new growth opportunities due to increasing investments in forensic infrastructure. Overall, the market is set to expand steadily as demand for advanced investigative tools increases.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application

• Law enforcement
• Biodefense
• Healthcare
• Others

By Source

• Blood
• Bones
• Hair
• Others

By Technique

• Polymerase Chain Reaction (PCR)
• Restriction Fragment Length Polymorphism (RFLP)
• Short Tandem Repeat (STR) analysis

COMPANIES PROFILED

• Agilent Technologies Inc., EasyDNA, F. Hoffmann-La Roche Ltd, GE Healthcare, Thermo Fisher Scientific Inc., Illumina Inc., Promega Corporation, QIAGEN, LGC Limited